Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population

NCT00137033 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

605

Enrollment

INDUSTRY

Sponsor class

Conditions

Peptic Ulcers

Interventions

DRUG: Celecoxib
DRUG: Naproxen
DRUG: ASA

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.